EULAR 2020

Complete Coverage

Inclusion of Non-Criteria Features to SLE Classification Improves Diagnostic Accuracy

By

Morgan E. Meissner

Publish Date June 17, 2020

Researchers identified criteria and non-criteria features associated with SLE, which can be used in classification criteria.

Safety, Efficacy of Upadacitinib vs Abatacept in Patients With Moderate to Severe RA

By

Brian Park, PharmD

Publish Date June 15, 2020

Results from the phase 3 SELECT-CHOICE study comparing treatment with upadacitinib to abatacept, a selective T cell costimulation modulator, in adults with moderate to severe active rheumatoid arthritis.

Anti-Acid Therapy Not Recommended in Systemic Sclerosis Interstitial Lung Disease

By

Britt Gambino

Publish Date June 6, 2020

Researchers evaluated the effect of anti-acid treatment on disease progression in systemic sclerosis interstitial lung disease.

Avacopan May Be Safe, Efficacious, and Superior to Other Treatments in ANCA-Associated Vasculitis

By

Alyssa Capel

Publish Date June 5, 2020

Researchers evaluated the efficacy and safety of avacopan for the treatment of ANCA-associated vasculitis.

Comparative Effects of csDMARDs on Stroke and Myocardial Infarction Risk in Rheumatoid Arthritis

By

Morgan E. Meissner

Publish Date June 5, 2020

Researchers quantified the comparative effect of csDMARDs on the risk for myocardial infarction and stroke in rheumatoid arthritis.

Interferon Inhibition With Anifrolumab Reduces Disease Activity in Systemic Lupus Erythematosus

By

Emily Pond

Publish Date June 5, 2020

An investigational type 1 interferon receptor inhibitor was associated with significant reduction in disease activity in patients with systemic lupus erythematosus.

Juvenile Idiopathic Arthritis Associated With Autism Spectrum Condition Diagnosis

By

Madeline Morr

Publish Date June 5, 2020

The association between juvenile idiopathic arthritis and autism spectrum condition was explored.

Elevated Risk for Aortic Valve Regurgitation in Ankylosing Spondylitis

By

Emily Pond

Publish Date June 5, 2020

Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.

Q&A: Study of Lenabasum in dcSSc Shows Immunosuppressive Therapy Variability by Geographic Region

By

Meghna Rao

Publish Date June 5, 2020

In a study of lenabasum treatment in systemic sclerosis, researchers evaluated variability of immunosuppressive therapy by geographic region; includes Q&A with study lead author, Dr Christopher Denton.

Active Conventional Therapy Linked to High, Early Remission Rates in Rheumatoid Arthritis

By

Emily Pond

Publish Date June 5, 2020

The efficacy of active conventional therapy in early rheumatoid arthritis was examined.